TURKEY'S FIRST ACCREDITED PHARMA R&D CENTER

Since the day it was founded, Abdi İbrahim has always benefited from a strong R&D culture. It still operates with high technology through its labs that develop the newest formulations and analytical methods with its approximately 120 researchers.

Abdi İbrahim R&D Center has the capability and infrastructure to develop pharmaceuticals through inhalation technology and nanotechnology to meet the ever changing and prograssive needs of the national and international pharma industries.

R&D Center focuses on developing added value and innovative products, achieving high success rate in bioequivalence studies, accelerating the process for bioequivalent product development and preparing Common Technical Document files for Turkey, Europe and other markets.

In addition to in-house projects, Abdi İbrahim also carries out joint projects with local and foreign scientific institutions and universities that result in know-how and technology transfers.

Formulation Technologies for innovative products:

• Orally disintegrating tablets
• Multi-layered tablets
• Drug development using nanotechnology
• Dry powder inhalers

Image Gallery

SITE MAP
INFORMATION SOCIETY SERVICES
© 2011-2017 Abdi İbrahim İlaç Sanayi ve Tic A.Ş.
The information provided on this site is not intended as an advice. Information provided should be discussed with your healthcare professional.
Phone: 0212 366 8400
E-Mail: info@abdiibrahim.com.tr